Thanks for taking the time to collate those. They should be a good reference for those who want to research Cantrixil further. As I stated earlier I don't think the market is attributing any value to Cantrixil at the moment so I don't think it is material to our prospects in the medium term. It would be a bonus if development continues under a partnership.
- Forums
- ASX - By Stock
- KZA
- Ann: paxalisib PNOC collaboration
Ann: paxalisib PNOC collaboration, page-19
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)